Terms: = Uterine cancer AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Treatment
7 results:
1. Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial cancer.
Vergote I; Pérez-Fidalgo JA; Hamilton EP; Valabrega G; Van Gorp T; Sehouli J; Cibula D; Levy T; Welch S; Richardson DL; Guerra EM; Scambia G; Henry S; Wimberger P; Miller DS; Klat J; Martínez-Garcia J; Raspagliesi F; Pothuri B; Romero I; Bergamini A; Slomovitz B; Schochter F; Høgdall E; Fariñas-Madrid L; Monk BJ; Michel D; Kauffman MG; Shacham S; Mirza MR; Makker V;
J Clin Oncol; 2023 Dec; 41(35):5400-5410. PubMed ID: 37669480
[TBL] [Abstract] [Full Text] [Related]
2. Selinexor in patients with advanced and recurrent endometrial cancer.
Bogani G; Monk BJ; Coleman RL; Vergote I; Oakin A; Ray-Coquard I; Mariani A; Scambia G; Raspagliesi F; Bolognese B
Curr Probl Cancer; 2023 Dec; 47(6):100963. PubMed ID: 37271639
[TBL] [Abstract] [Full Text] [Related]
3. Interference with xpo1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical cancer Cells via Binding with Rad21.
Song G; Ren J; Li Y; Cui J
Ann Clin Lab Sci; 2023 Mar; 53(2):278-292. PubMed ID: 37094850
[TBL] [Abstract] [Full Text] [Related]
4. treatment options for molecular subtypes of endometrial cancer in 2023.
Karpel HC; Slomovitz B; Coleman RL; Pothuri B
Curr Opin Obstet Gynecol; 2023 Jun; 35(3):270-278. PubMed ID: 36943683
[TBL] [Abstract] [Full Text] [Related]
5. xpo1-Mediated EIF1AX Cytoplasmic Relocation Promotes Tumor Migration and Invasion in Endometrial Carcinoma.
Ye Y; Lv C; Sun J; Lin Z; Liu Y; Huang Y; Chen Y; Li H; Lian X; Jiang X; Zhang S; Wang S
Oxid Med Cell Longev; 2022; 2022():1361135. PubMed ID: 36589683
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of crm1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death.
Fabi F; Adam P; Vincent K; Demontigny F; Parent S; Joncas FH; Asselin E
Cell Commun Signal; 2018 Jul; 16(1):39. PubMed ID: 29973205
[TBL] [Abstract] [Full Text] [Related]
7. Identification of biomarkers for radiation-induced acute intestinal symptoms (RIAISs) in cervical cancer patients by serum protein profiling.
Chai Y; Wang J; Gao Y; Wang T; Shi F; Su J; Yang Y; Zhou X; Song L; Liu Z
J Radiat Res; 2015 Jan; 56(1):134-40. PubMed ID: 25256248
[TBL] [Abstract] [Full Text] [Related]
